The optimal management of T1 high-grade bladder cancer

Authors

  • Kenneth G. Nepple University of Iowa Department of Urology, Iowa City, IA
  • Michael A. O’Donnell University of Iowa Department of Urology, Iowa City, IA

DOI:

https://doi.org/10.5489/cuaj.1194

Abstract

Stage T1Hg bladder cancer should be considered an aggressive and
potentially lethal disease. The importance of initial re-resection to
identify unrecognized muscle-invasive disease is significant. Most
patients with high-risk disease are candidates for initial bladder salvage
with intravesical bacillus Calmette-Guerin vaccine for
immunotherapy, a procedure with a high survival rate; however,
failure of the procedure may result in a guarded prognosis. Even
after apparent success, patients should be informed of the risks of
the disease progressing to muscle-invasive or metastatic disease
and the need for vigilant monitoring. Despite optimal management,
a significant number of patients relapse or progress to invasive disease
requiring cystectomy. This review provides insight into the
optimal management of T1 high-grade bladder cancer.

Downloads

Download data is not yet available.

Author Biographies

Kenneth G. Nepple, University of Iowa Department of Urology, Iowa City, IA

Michael A. O’Donnell, University of Iowa Department of Urology, Iowa City, IA

Downloads

How to Cite

Nepple, K. G., & O’Donnell, M. A. (2013). The optimal management of T1 high-grade bladder cancer. Canadian Urological Association Journal, 3(6-S4), S188-S192. https://doi.org/10.5489/cuaj.1194